FGAM
PTGX icon

Financial Gravity Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Financial Gravity Asset Management’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$7K Hold
55
– – ﹤0.01% 1237
2019
Q3 		$1K Hold
55
– – ﹤0.01% 1092
2019
Q2 		$1K Hold
55
– – ﹤0.01% 1116
2019
Q1 		$1K Buy
+55
New +$485 ﹤0.01% 1166
2018
Q3 		$0 Hold
55
– – ﹤0.01% 1572
2018
Q2 		$1K Buy
55
+53
+2,650% +$407 ﹤0.01% 1242
2018
Q1 		$0 Buy
+2
New +$38 ﹤0.01% 1483

Other funds holding PTGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Financial Gravity Asset Management's PTGX Position: Q4 2019 in Review

Financial Gravity Asset Management held its Protagonist Therapeutics (PTGX) position steady in Q4 2019 at 55 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.

Financial Gravity Asset Management first reported a position in PTGX in Q1 2018 and has held it in 7 quarters since. 81 funds tracked by Wall St. Rank hold PTGX as of Q4 2019.

  • Financial Gravity Asset Management held 55 shares of Protagonist Therapeutics worth $7K as of Q4 2019.
  • Financial Gravity Asset Management left its Protagonist Therapeutics share count unchanged in Q4 2019.
  • Protagonist Therapeutics made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q4 2019, its #1237 holding.
  • Financial Gravity Asset Management first reported a position in Protagonist Therapeutics in Q1 2018 and has held it in 7 quarters since.
  • 81 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.